Bonraybio Co., Ltd. (TPE:6955)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
145.50
-4.50 (-3.00%)
At close: May 29, 2026
Market Cap3.61B +14.2%
Revenue (ttm)319.67M +30.1%
Net Income102.36M +30.9%
EPS4.11 +22.6%
Shares Out 24.80M
PE Ratio35.40
Forward PEn/a
Dividend1.50 (1.03%)
Ex-Dividend DateMar 19, 2026
Volume36,110
Open150.00
Previous Close150.00
Day's Range145.00 - 150.00
52-Week Range145.00 - 186.96
Beta0.11
Analystsn/a
Price Targetn/a
Earnings DateMay 27, 2026

About Bonraybio

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was found... [Read more]

Sector Healthcare
Founded 2015
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, Bonraybio's revenue was 306.31 million, an increase of 37.43% compared to the previous year's 222.88 million. Earnings were 102.51 million, an increase of 49.94%.

Financial Statements